What tests should you use to assess small intestinal bacterial overgrowth in systemic sclerosis?

OBJECTIVES Small intestinal bacterial overgrowth (SIBO) plays a major role in the pathogenesis of malabsorption in SSc patients and is a source of great morbidity and even mortality, in those patients. This manuscript reviews which tests are valid and should be used in SSc when evaluating SIBO. METHODS We performed systematic literature searches in PubMed, Embase and the Cochrane library from 1966 up to November 2014 for English language, published articles examining bacterial overgrowth in SSc (e.g. malabsorption tests, breath tests, xylose test, etc). Articles obtained from these searches were reviewed for additional references. The validity of the tests was evaluated according to the OMERACT principles of truth, discrimination and feasibility. RESULTS From a total of 65 titles, 22 articles were reviewed and 20 were ultimately extracted to examine the validity of tests for GI morphology, bacterial overgrowth and malabsorption in SSc. Only 1 test (hydrogen and methane breath tests) is fully validated. Four tests are partially validated, including jejunal cultures, xylose, lactulose tests, and 72 hours fecal fat test. CONCLUSIONS Only 1 of a total of 5 GI tests of bacterial overgrowth (see above) is fully validated in SSc. For clinical trials, fully validated tests are preferred, although some investigators use partially validated tests (4 tests). Further validation of GI tests in SSc is needed.

[1]  L. Barbot,et al.  Prevalence and predictors of small intestinal bacterial overgrowth in systemic sclerosis patients with gastrointestinal symptoms. , 2014, Clinical and Experimental Rheumatology.

[2]  M. Pimentel,et al.  Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance , 2013, Therapeutic advances in chronic disease.

[3]  A. Gasbarrini,et al.  Gastrointestinal motility disorder assessment in systemic sclerosis. , 2013, Rheumatology.

[4]  E. Savarino,et al.  Lactulose breath test to assess oro-cecal transit delay and estimate esophageal dysmotility in scleroderma patients. , 2013, Seminars in arthritis and rheumatism.

[5]  S. Vanner,et al.  Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS , 2010, Gut.

[6]  P. Ducrotte,et al.  Small intestinal bacterial overgrowth in systemic sclerosis. , 2009, Rheumatology.

[7]  R. Hays,et al.  Reliability and validity of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument. , 2009, Arthritis and rheumatism.

[8]  A. Gasbarrini,et al.  Methodology and Indications of H2‐Breath Testing in Gastrointestinal Diseases: the Rome Consensus Conference , 2009, Alimentary pharmacology & therapeutics.

[9]  E. Savarino,et al.  Small Intestinal Bacterial Overgrowth in Patients Suffering From Scleroderma: Clinical Effectiveness of Its Eradication , 2008, The American Journal of Gastroenterology.

[10]  M. Csuka,et al.  Severe gastrointestinal involvement in systemic sclerosis: report of five cases and review of the literature. , 2005, Seminars in arthritis and rheumatism.

[11]  G. Simon,et al.  The human intestinal microflora , 1986, Digestive Diseases and Sciences.

[12]  F. Wollheim,et al.  Gastrointestinal function in patients with progressive systemic sclerosis , 1985, Clinical Rheumatology.

[13]  Anil Minocha,et al.  Reliability and Reproducibility of Breath Hydrogen and Methane in Male Diabetic Subjects , 1997, Digestive Diseases and Sciences.

[14]  G. Valentini,et al.  Assessment of intestinal permeability and orocecal transit time in patients with systemic sclerosis: analysis of relationships with epidemiologic and clinical parameters , 2003, Rheumatology International.

[15]  T. Gordon,et al.  Antibody-mediated gastrointestinal dysmotility in scleroderma. , 2002, Gastroenterology.

[16]  G. Valentini,et al.  Proximal stomach function in systemic sclerosis: relationship with autonomic nerve function. , 2001, Digestive Diseases and Sciences.

[17]  P. Stotzer,et al.  Comparison of the 1-Gram 14C-D-Xylose Breath Test and the 50-Gram Hydrogen Glucose Breath Test for Diagnosis of Small Intestinal Bacterial Overgrowth , 2000, Digestion.

[18]  J. Schölmerich,et al.  Gastrointestinal manifestations of progressive systemic sclerosis. , 1997, The American journal of gastroenterology.

[19]  R. Sjogren.  Gastrointestinal features of scleroderma. , 1996, Current opinion in rheumatology.

[20]  S. Riordan,et al.  The lactulose breath hydrogen test and small intestinal bacterial overgrowth. , 1996, The American journal of gastroenterology.

[21]  S. Gillespie,et al.  Small bowel bacterial overgrowth in systemic sclerosis: detection using direct and indirect methods and treatment outcome. , 1995, British journal of rheumatology.

[22]  R. Sjogren,et al.  Gastrointestinal motility disorders in scleroderma. , 1994, Arthritis and rheumatism.

[23]  A. Kahan,et al.  Gastrointestinal involvement in systemic sclerosis. , 1994, Clinics in dermatology.

[24]  R. Russell,et al.  Bacterial overgrowth without clinical malabsorption in elderly hypochlorhydric subjects. , 1994, Gastroenterology.

[25]  C. Owyang.  Octreotide in gastrointestinal motility disorders. , 1994, Gut.

[26]  W. Hasler,et al.  Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. , 1991, The New England journal of medicine.

[27]  G. Corazza,et al.  The diagnosis of small bowel bacterial overgrowth: Reliability of jejunal culture and inadequacy of breath hydrogen testing , 1990 .

[28]  G. Corazza,et al.  The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing. , 1990, Gastroenterology.

[29]  H. Worning,et al.  Exocrine pancreatic function in patients with progressive systemic sclerosis. , 1989, Scandinavian journal of gastroenterology.

[30]  P. Kerlin,et al.  Breath hydrogen testing in bacterial overgrowth of the small intestine. , 1988, Gastroenterology.

[31]  P. Toskes,et al.  Comparison of the 1-gram [14C]xylose, 10-gram lactulose-H2, and 80-gram glucose-H2 breath tests in patients with small intestine bacterial overgrowth. , 1986, Gastroenterology.

[32]  A. Axon,et al.  Small intestinal structure and passive permeability in systemic sclerosis. , 1980, Gut.

[33]  J. McGoldrick,et al.  Small intestinal bacterial growth in systemic sclerosis , 1980, Clinical and experimental dermatology.

[34]  D. Jewell,et al.  The lactulose hydrogen breath test as a diagnostic test for small-bowel bacterial overgrowth. , 1979, Scandinavian journal of gastroenterology.

[35]  A. Hofmann,et al.  Clinical value of the bile acid breath test. Evaluation of the Mayo Clinic experience. , 1978, Mayo Clinic proceedings.

[36]  B. Drasar,et al.  BREATH-HYDROGEN TEST FOR SMALL-INTESTINAL BACTERIAL COLONISATION , 1976, The Lancet.

[37]  A. Hofmann,et al.  Sensitivity and specificity in tests of distal ileal function: prospective comparison of bile acid and vitamin B 12 absorption in ileal resection patients. , 1973, Gastroenterology.

[38]  R. Fisher,et al.  The pathogenesis of esophageal dysfunction in scleroderma and Raynaud's disease. , 1972, The Journal of clinical investigation.